Saturday, February 1, 2014

TAKE Solutions Q3 FY 14 results

TAKE Solutions Ltd. [BSE: 532890 | NSE: TAKE], a global business technology solutions provider with significant focus across two principal business areas, namely Life Sciences (LS) and Supply Chain Management (SCM) domains, today, announced the financial results for the quarter ended December 31st, 2013. The company has posted net profit of INR 167 Mn for this quarter, which is a 10.6% increase against the previous quarter. The board also announced an interim dividend of 30%.

Srinivasan H.R., Vice-Chairman and Managing Director, TAKE Solutions said, “Our performance this quarter was better than our expectations. The strategy to emphasise on the Life Sciences business envisaged by the management at the start of the financial year has started showing results. We have had significant wins in Life Sciences during the quarter, establishing the strong association with our clients.” He further added, “We expanded our offerings in this space to have 360 degree exposure of the Pharma / Biotech R&D market – clinical, regulatory and safety. Furthermore, our investments in enhancing our go-to-market strategies have also enabled us to acquire new clients and expand our offerings to the existing clients.”

About TAKE Solutions:
TAKE Solutions Ltd. [BSE: 532890 | NSE: TAKE] is a leading global business technology company with domain expertise in Life Sciences (LS) and Supply Chain Management (SCM). TAKE provides cost-effective and comprehensive solutions for enterprises across diverse sectors including pharmaceuticals, high technology, consumer packaged goods, oil/gas, and automotive. TAKE’s SCM product suite includes distinct technology with embedded IP that spans enterprise mobility, trading partner collaboration, and material tracking. In the LS domain, TAKE offers IP-based software and extensive knowledge-based solutions to enable efficient clinical, regulatory, safety and commercialization processes. TAKE has been recognized as a ‘Leader’ in IDC Health Insights’ “IDC MarketScape: Worldwide Life Science Drug Safety Services 2013 Vendor Assessment”. TAKE’s global headquarters is in Chennai, India; its U.S. headquarters is located in Princeton, New Jersey. TAKE has a proven track record as a trusted partner in delivering world-class solutions to more than 400 customers worldwide. For more information, please visit www.takesolutions.com.